Main Article Content
Welcome to Volume 1, Issue 3 of SKIN: The Journal of Cutaneous MedicineTM. We thank you, the readership of SKIN, for all of your feedback and suggestions. As a journal made by dermatologists for dermatologists, we are constantly looking for ways to implement new features aimed at serving the needs of the dermatology community. As such, we are excited to announce several new features of that are debuting with the publication of Volume 1, Issue 3.
In order to keep abreast of current trends and issues in the specialty, each future issue will feature a one-on-one interview with a leader in dermatology or industry as part of our new “A View from the Top” series, starting with Bill Humphries, Executive Vice President of Ortho Dermatologics. In this section, distinguished individuals will provide insight into the state of the specialty, including current challenges faced by clinicians.
Also beginning with this issue, we will be highlighting a featured article, selected by the editorial team due to the timeliness and pertinence of the information provided within. We are pleased to announce our first featured article, “Acute Generalized Exanthematous Pustulosis in Association with Hydroxyzine and Cetrizine” by Nevo, et. al. We believe that this article will provide important new information for the practicing dermatologist.
One of our goals at SKIN is to incorporate the use of technology in order to aid in the widespread dissemination of dermatologic knowledge. With this spirit in mind, we are excited to announce the inclusion of a new section featuring videos of CME lectures with timely information. The first 2 of these video presentations are from the 2017 Fall Clinical Dermatology Conference®:
“What’s New in the Medicine Chest, Part 1” by James Del Rosso, DO,
“Therapeutic Update” by Gary Goldenberg, MD.
The Editors of SKIN hope that you will find all of these new features to be of value. As always, we look forward to your thoughts and ideas of how we can continue to make SKIN optimize its value to you.